Acetylcholine inhib 
Welcome,         Profile    Billing    Logout  
 28 Companies  30 Products   30 Products   411 Diseases   275 Trials   15545 News 
447 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Dysport (abobotulinumtoxinA) / Ipsen
2004-005194-27: Anti-inflammatory and/or antinociceptive effects of botulinum toxin A in an experimental inflammatory human skin pain model: a randomised, double blinded, placebo controlled study

Ongoing
4
6
Europe
Dysport, 11101-0309-6, Solution for injection
Department of Neurology, Medical University of Vienna
not applicableIn this trial a potential antinociceptive potency af the IMP (Dysport) will be testet i9n a human inflammatory pain model. The present study will only include heathy volunteers.
 
 
2005-004011-30: A prospective open study evaluating the use of botulinum toxin in patients with overactive bladder as an alternative to other conservative treatments.

Ongoing
4
100
Europe
Dysport, botulinum toxin, Dysport, Dysport
Gwent Healthcare NHS Trust
Overactive bladder syndrome is characterized by a combination of urinary frequency, urgency and urge incontinence.
 
 
2008-005819-18: A comparison of Dysport (100 U/ml) and Botox (100 U/ml) using dose conversion factor 3:1 and 1.7:1 in the treatment of cervical dystonia.

Ongoing
4
75
Europe
Botox, Dysport, Botox, Dysport, Botox, Dysport
Department of Neuroscience, Uppsala University
Cervical dystonia, not multifocal or generalised dystonia.
 
 
2009-012073-34: Botulinum toxin for treating calf muscle spasticity in Hereditary Spastic Paraparesis (HSP): functional effects on dynamic balance and gait

Ongoing
4
20
Europe
Dysport, Dysport, Dysport
Radboud University Nijmegen Medical Centre
Subjects with hereditary spastic paraparesis (HSP)
 
 
2009-013684-19: Studie av botulinumtoxiners anhidrotiska (svettreducerande) effekt beroende på använd koncentration.

Ongoing
4
20
Europe
Botox, Dysport, Xeomin, Neurobloc, Botox, Dysport, Xeomin, Neurobloc, Botox, Dysport, Xeomin, Neurobloc
Uppsala läns landsting
Studien kommer att utföras på friska försökspersoner. Anhidrotisk (svettreducerande) effekt samt durationen av denna kommer att undersökas efter injektioner med botulinumtoxin.Resultaten från studien kommer senare att appliceras vid behandling av patienter med sjukdomen hyperhidros.
 
 
2010-021265-80: Injections intradétrusoriennes de toxine botulique A chez l\'enfant présentant un syndrome d\'hyperactivité vésicale neurogène : essai thérapeutique contrôlé multicentrique de non infériorité entre deux doses rapportées au poids.

Ongoing
4
250
Europe
DYSPORT 500 UNITES SPEYWOOD, DYSPORT 500 UNITES SPEYWOOD
Centre Hospitalier Universitaire de Reims
Syndrome d\'hyperactivité vésicale neurogène chez l\'enfant
 
 
2012-002938-37: NA Comprobación del efecto clínico de tres toxinas botulínicas tipo A, sobre líneas verticales del entrecejo (líneas glabelares).

Ongoing
4
60
Europe
Vistabel, Bocouture, Azzalure, Vistabel, Bocouture, Azzalure, Vistabel®, Bocouture®, Azzalure®, Vistabel®, Bocouture®, Azzalure®
DR. JAVIER ANIDO RUBIO, Merz Pharma S.A
NA Se trata de sujetos que requieren tratamiento con toxina botulínica para las arrugas del entrecejo (líneas glabelares) de moderadas a profundas.
 
 
2016-001378-13: A randomized, sham-controlled trial which compare the deep brain stimulation of a specific brain region against a conventional botulinum toxine treatment for cervical dystonia. Eine randomisierte, scheinkontrollierte Studie, die die tiefe Hirnstimulation eine speziellen Hirnregion mit einer herkömmlichen Botulinumtoxintherapie bei zervikaler Dystonie vergleicht.

Not yet recruiting
4
66
Europe
Botulinumtoxin Type A, Powder for solution for injection, Botox(R) 50, Botox(R) 100, Botox(R) 200, Dysport(R) 300, Dysport(R) 500, XEOMIN(R) 50, XEOMIN(R) 100
University Hospital Wuerzburg, Federal Ministry of Education and Research (BMBF), Medtronic GmbH
cervical dystonia zervikale Dystonie, Torticollis spasmodicus Schief- bzw. Fehlhaltung des Halses, Diseases [C] - Nervous System Diseases [C10]
 
 
2017-004497-33: Measuring effects on pain and quality of life after botulinium injections (DYSPORT® ) in children with cerebral palsy Effekten af Botulinum toxin A injektioner (DYSPORT®) på muskelsmerter og livskvalitet hos børn med cerebral parese

Ongoing
4
36
Europe
DYSPORT® (abotulinumtoxinA), Injection, DYSPORT® (abotulinumtoxinA)
Copenhagen University Hospital at Hvidovre, Ipsen
Muscle pain in the lower extremities due to spasticity in children with cerebral palsy, Muscle pain in the legs due to spasticity in children with cerebral palsy, Diseases [C] - Nervous System Diseases [C10]
 
 
NCT06250543: Evaluation of Intradetrusor AbobotulinumtoxinA and IncobotulinumtoxinA in Women With Overactive Bladder

Completed
4
64
Europe
AbobotulinumtoxinA 300 UNT, IncobotulinumtoxinA 100 UNT, Lidocain, placebo
Niko Kavcic
Overactive Bladder
11/22
11/22
NCT02840838: Botulinum Toxin for Post Abdominoplasty Pain Control

Not yet recruiting
4
50
NA
Dysport, Placebo
Virginia Commonwealth University
Pain, Activity
12/19
12/19
NCT03136341: A Cross Over Pilot Study of Abobotulinum Toxin A (Dysport) as a Treatment for Task-dependent Upper Limb Tremor

Recruiting
4
25
US
Abobotulinum toxin A, Placebo
David M. Simpson, Ipsen
Tremor, Limb
12/22
12/22
NCT06336785: Kiss and Smile HIT (Holistic Individualized Treatment)

Completed
4
24
Canada
Restylane line of soft tissue fillers and Dysport neuromodulator
Erevna Innovations Inc.
Aesthetic
11/24
12/24
NCT03935295: Dysport ® as an Adjunctive Treatment to Bracing in the Management of Adolescent Idiopathic Scoliosis

Recruiting
4
90
US
AbobotulinumtoxinA, Dysport, Ipsen, Placebos, Custom Thoracolumbosacral Orthosis
Johns Hopkins University
Adolescent Idiopathic Scoliosis
12/25
03/26
DIRECTION, NCT04936542 / 2021-000161-32: A Study to Compare the Safety and Efficacy of Dysport® and Botox® in Adults With Upper Limb Spasticity.

Active, not recruiting
4
464
Europe, Canada, US
AboBoNT-A, Dysport®, OnaBoNT-A, Botox®
Ipsen, Ipsen Pharma
Upper Limb Spasticity
10/25
10/25
CECS, NCT05466539: Chronic Exertional Compartment Syndrome () Treated With Abobotulinumtoxin A

Recruiting
4
42
US
AbobotulinumtoxinA, Intervention Group, Placebo, Control Group
Emory University, Ipsen
Compartment Syndrome of Leg
07/25
07/25
2018-003231-30: EFFECTIVENESS OF REPEATED INJECTIONS OF BOTULINUM TOXIN IN THE GAIT AND QUALITY OF LIFE OF ADULT PATIENTS WITH WEAKNESS AND MUSCLE RIGIDITY DUE TO MULTIPLE ESCLEROSIS EFICACIA DE INYECCIONES REPETIDAS DE TOXINA BOTULÍNICA EN LA MARCHA Y CALIDAD DE VIDA DE PACIENTES ADULTOS CON DEBILIDAD Y RIGIDEZ MUSCULAR DEBIDA A ESCLÉROSIS MÚLTIPLE

Ongoing
3
84
Europe
Powder for solution for injection, Dysport
Aránzazu Vázquez Doce, IPSEN
Multiple sclerosis Esclérosis múltiple, Multiple sclerosis Esclérosis múltiple, Diseases [C] - Nervous System Diseases [C10]
 
 
2021-000161-32: A Study to Compare the Safety and Efficacy of Dysport® and Botox® in Adults with Upper Limb Spasticity Étude visant à comparer l’innocuité et l’efficacité du Dysport® par rapport au Botox® dans le traitement de patients adultes atteints de spasticité du membre supérieur

Not yet recruiting
3
564
Europe
Powder for solution for injection, Dysport® 500 U powder for solution for injection, Botox® 200 U powder for solution for injection
Ipsen Pharma, Ipsen Pharma
upper limb spasticity (ULS) of any aetiology (in US and France) or post-stroke ULS (in Canada) spasticité du membre supérieur (SMS) de toute étiologie (aux USA et en France) ou SMS postérieure à un accident vasculaire cérébral (au Canada), Upper limb spasticity is a medical condition when upper limb muscles are tight or in spasm and need to be relaxed. La spasticité du membre supérieur est une condition médicale dans laquelle les muscles dans membres supérieurs sont tendus ou contractés et ont besoin d'être relâchés, Diseases [C] - Nervous System Diseases [C10]
 
 
DNHFS, NCT04589364: Study of Abobotulinum Toxin Versus Neubotulinum Toxin Injection For Hemifacial Spasm in Thai Patients

Not yet recruiting
3
120
RoW
Injection botulinum toxin A ( Dysport 100 unit or Neuronox 33.33 unit)
Rajavithi Hospital
Hemifacial Spasm
06/26
08/26
NCT06946160: A Non-inferiority Clinical Trial to Compare Efficacy and Safety of Abobotulinumtoxin A (Espad Pharmed) Versus AbobotulinumtoxinA (Dysport®, Ipsen Co.) for Correction of Moderate to Severe Glabellar Lines

Completed
3
146
RoW
Abobotulinumtoxin A for Injection
Espad Pharmed, Center for Research and Training in Skin Diseases and Leprosy
Glabellar Lines, Glabellar Wrinkle
02/25
02/25
C-BEOND, NCT06047444: A Study to Evaluate the Effectiveness and Safety of Dysport® for the Prevention of Chronic Migraine in Adults

Recruiting
3
720
Europe, Canada, US, RoW
Botulinum toxin type A, Dysport®, Placebo
Ipsen
Chronic Migraine
06/26
12/26
E-BEOND, NCT06047457: A Study to Evaluate the Effectiveness and Safety of Dysport® for the Prevention of Episodic Migraine in Adults

Recruiting
3
714
Europe, Canada, US, RoW
Botulinum toxin type A, Dysport®, Placebo
Ipsen
Episodic Migraine
06/26
12/26
NCT04756882: Clinical Evaluation of the Efficacy OF Botulinum Toxin A for Improving Facial Scars

Active, not recruiting
2/3
12
RoW
AbobotulinumtoxinA 500 UNT, Dysport
Alexandria University
Hypertrophic Scarring
05/21
09/21
EBTox, NCT03453632: Injections of Botulinic Toxin in Plantar Lesions of Localized Epidermolysis Bullosa Simplex

Recruiting
2/3
25
Europe
Botulinic toxin, Dysport® (experimental drug), Placebo, physiological serum
University Hospital, Toulouse
Epidermolysis Bullosa Simplex
09/23
12/23
NCT05478551: Randomized Controlled Trial Examining the Efficacy of Botulinum Toxin in Biopsy Scar Minimization

Active, not recruiting
2/3
12
US
Botulinum Toxin, Dysport, BTXa, abobotulinumtoxinA, Normal saline, Placebo
Henry Ford Health System
Scar, Hypertrophic Scar
12/24
12/24
NCT03887377: The Efficacy and Molecular Mechanism of Botulinum Toxin in the Reduction of Breast Reduction Mammoplasty Scar Formation

Enrolling by invitation
2/3
22
US
Botulinum Toxins, Dysport, BTXa, abobotulinumtoxinA, Normal saline, Placebo
Henry Ford Health System, Galderma R&D
Scar, Hypertrophic Scar, Mammary Disorder
12/24
12/24
2012-003479-20: Study of treatment of tennis elbow with Botox. Undersökning av behandling av tennisarmbåge med Botox

Ongoing
2
50
Europe
botulinum toxin, Powder for solution for injection, Dysport
Handkirurgiska kliniken, Universitetssjukhuset Örebro, Handkirurgiska kliniken, Universitetssjukhuset Örebro
Chronic lateral humerus epiconcylitis Kronisk lateral humerusepikondylit., Tennis elbow Tennisarmbåge., Diseases [C] - Musculoskeletal Diseases [C05]
 
 
2005-005235-96: A Double-Blind Comparison of the Safety and Efficacy of Dysport® and BOTOX® (Botulinum Toxin Type A) in the Treatment of Female Subjects with Severe Glabellar Rhytids

Ongoing
2
60
Europe
BOTOX®, Dysport®, N/A, BOTOX®, Dysport®, BOTOX®, Dysport®
Cranley Clinic
Severe glabellar rhytids
 
 
2005-004996-40: A Prospective, Single-Arm, Open-label Study to Investigate the Efficacy and Safety of Intravesical Injection of Botulinum Toxin Type-A (750 Units Dysport®) for the Management of Neurogenic Detrusor Overactivity.

Ongoing
2
50
Europe
Dysport, N/A, Dysport, Dysport
R and D Department, Cardiff and the Vale NHS Trust
Neurogenic detrusor overactivity
 
 
2005-004995-20: A Prospective, Single-Arm, Open-label Study to Investigate the Efficacy and Safety of Intravesical Injection of Botulinum Toxin Type-A (500 Units Dysport®) for the Management of Idiopathic Overactive Bladder Syndrome.

Ongoing
2
50
Europe
Dysport, N/A, Dysport, Dysport
R and D Department, Cardiff and the Vale NHS Trust
Idiopathic Overactive bladder syndrome
 
 
2010-022165-10: Klinische Studie zur Induktion einer Apoptose von Prostatazellen durch die Injektion von Botulinumtoxin A bei Patienten mit benigner Prostatahyperplasie

Ongoing
2
35
Europe
Dysport® 500 Einheiten, Pulver zur Herstellung einer Injektionslösung, Dysport® 500 Einheiten, Pulver zur Herstellung einer Injektionslösung
Prim. Univ.-Prof. Dr. Günter Janetschek c/o Universitätsklinik für Urologie und Andrologie
Benigne Prostatahyperplasie mit Inoperabilität und transurethralem Dauerkatheter
 
 
2018-001703-37: Dysport in Post-Surgical Neuralgia (RESPITE)

Not yet recruiting
2
60
Europe
Dysport, Solution for infusion, Dysport
Ipsen Innovation SAS, Ipsen Innovation SAS
Post-Surgical neuralgia, Chronic scar-related pain after surgery, Diseases [C] - Nervous System Diseases [C10]
 
 
2019-003503-35: Studies of the treatment effect of botulinum toxin A on patients with neurogenic pain in the mouth

Not yet recruiting
2
37
Europe
Powder for solution for injection, Dysport
Region Östergötland, Folktandvården, Region Östergötland
Atypical Odontalgia/Persistent Dentoalveolar Pain, Neurogenic pain in the mouth, Analytical, Diagnostic and Therapeutic Techniques and Equipment [E] - Dentistry [E06]
 
 
2021-006048-29: BotulInum toxin type A for peripheral Neuropathic pain in subjEcts with Carpal Tunnel syndrome: a multicenter, randomized, double-blind, placebo-controlled study Studio multicentrico, randomizzato, in doppio cieco, controllato con placebo per valutare l’efficacia e la sicurezza della tossina botulinica di tipo A per il dolore neuropatico periferico in soggetti con sindrome del tunnel carpale.

Not yet recruiting
2
164
Europe
Tossina botulinica tipo A da C. botulinum complesso - emoagglutinina, [Dysport 500 unità], Powder and solvent for solution for injection/infusion, Dysport
AOU MATERDOMINI, Ipsen
Peripheral neuropathic pain in subjects with carpal tunnel syndrome Dolore neuropatico periferico in soggetti con sindrome del tunnel carpale, Peripheral neuropathic pain in subjects with carpal tunnel syndrome Dolore neuropatico periferico in soggetti con sindrome del tunnel carpale, Body processes [G] - Bones and nerves physological processes [G11]
 
 
NCT04965311: Endoscopic Botulinum Toxin Injection in the Prevention of Postoperative Pancreatic Fistula Following Distal Pancreatectomy

Recruiting
2
63
US
Botulinum Toxin Type A, AbobotulinumtoxinA, Botox, Botox Cosmetic, Botulinum A Toxin, Botulinum Neurotoxin Type A, Botulinum Toxin A, BTX-A, DaxibotulinumtoxinA, Dysport, EvabotulinumtoxinA, IncobotulinumtoxinA, OnabotulinumtoxinA, Onaclostox, Prabotulinumtoxin A, Xeomin
OHSU Knight Cancer Institute, Oregon Health and Science University
Pancreatic Carcinoma
05/25
05/25
2019-003948-71: A study investigating single injection of new botulinum toxin to determine safety and efficacy for treating spasticity in the upper limb

Ongoing
1/2
209
Europe, RoW
Dysport, IPN59011, Powder and solvent for solution for injection, Powder for solution for injection, Dysport
Ipsen Innovation, IPSEN INNOVATION, Ipsen Innovation
Upper limb spasticity after stroke or traumatic brain injury, Medical condition where Upper limb muscles are tight or in spasm after stroke or traumatic brain injury and needs to be relaxed., Diseases [C] - Nervous System Diseases [C10]
 
 
2020-003746-36: A study to assess the safety and efficacy of IPN10200 in adult participants with moderate to severe upper facial lines

Not yet recruiting
1/2
547
Europe
Dysport, IPN10200, Powder for solution for injection, Dysport
Ipsen Innovation, Ipsen Innovation
Treatment of Moderate to Severe Upper Facial Lines, Treatment of Moderate to Severe Upper Facial Lines, Body processes [G] - Physical Phenomena [G01]
 
 
NCT04886167: Dysport Dose-Ranging Treatment of Platysmal Bands

Active, not recruiting
1/2
30
US
AbobotulinumtoxinA, Dysport
Clinical Testing of Beverly Hills, Galderma R&D
Platysma Bands
11/22
11/22
LANTIC, NCT04821089 / 2020-003746-36: A Study to Assess the Safety and Efficacy of IPN10200 in Adult Participants With Moderate to Severe Upper Facial Lines

Recruiting
1/2
727
Europe
IPN10200, IPN10200 Placebo, Dysport
Ipsen, Ipsen Innovation
Moderate to Severe Upper Facial Lines
03/26
03/27
LANTIMA, NCT04752774 / 2020-003623-42: A Study to Assess the Safety and Efficacy of IPN10200 in Adult Participants With Upper Limb Spasticity.

Active, not recruiting
1/2
240
Europe, US, RoW
IPN10200, Placebo, Dysport
Ipsen
Spasticity
10/27
10/27
ACTRN12605000775617: Effectiveness of Botulinum toxin Type A injection (Dysport®) to restore quadriceps muscle balance and improve chronic knee pain

Active, not recruiting
1
25
 
Dr BJ Singer, School of Surgery and Pathology, The University of Western AustraliaMedical Research Foundation Building, Level 2, Rear 50 Murray Street, Perth, WA 6000, Raine Medical Research Foundation, Ipsen Pharmaceuticals
Chronic anterior knee pain?
 
 
EARLY BOT-SPAS, NCT06811142: Early Botulinum Toxin for Muscle Stiffness Reduction in First-Time Stroke Patients: Improving Recovery and Independence

Active, not recruiting
1
200
RoW
Botulinum Toxin Type A (BoNT-A), Botulinum Neurotoxin A, BoNT-A, AbobotulinumtoxinA
Instituto Mexicano del Seguro Social
Spasticity, Stroke, Neurological Rehabilitation
02/27
02/30
BTX, NCT06258070: Clinical Performance of Therapeutic Use of for Bruxism

Completed
N/A
67
RoW
Abobotulinumtoxin A injection for bruxism, Botulinum toxin injection for bruxism
Mohamed Tahar Maamouri University Hospital
Myofascial Pain Syndrome, Myofascial Trigger Point Pain, Bruxism, Pain
12/15
12/17
NCT04270214: Conversion to Dysport in CD

Active, not recruiting
N/A
33
Canada
Dysport Injectable Product, abobotulinumtoxinA
Western University, Canada
Cervical Dystonia
10/22
10/22
JBDX, NCT05167864: Evaluation of Four Injectable Neuromodulators in the Glabella Area Glabella Area

Completed
N/A
143
US
Onabotulinumtoxina for Injection, Botox, Abobotulinumtoxina for Injection, Dysport, IncobotulinumtoxinA for Injection, Xeomin, PrabotulinumtoxinA for Injection, Jeuveau
University of Pennsylvania
Cosmetic Techniques
06/23
06/23
NCT05089357: Non-interventional Study, Long Term Treatment on Glabellar Lines With Dysport® in Subjects of Chinese Origin

Completed
N/A
250
RoW
AbobotulinumtoxinA
Galderma R&D
Glabellar Lines
09/23
12/23
CARBUR, NCT06245772: CARegiver BURden, Effectiveness and Other Health Care Measures on Functional Disability, in Patients Treated With Abobotulinumtoxin A for Upper Limb Spasticity

Recruiting
N/A
133
Europe
Ipsen
Upper Limb Injury
07/25
09/26
RELY-CD, NCT05884528: Assessment of Long-term Clinical Response to BoNT in Cervical Dystonia

Completed
N/A
270
Europe
CC BoNT/A, onabotulinumtoxinA, abobotulinumtoxinA, CF BoNT/A, incobotulinumtoxinA, NT 201, Botulinum toxin type A (150 kiloDalton), free from complexing proteins, CF to CC BoNT/A, CC to CF BoNT/A
Merz Therapeutics GmbH, Heinrich-Heine University, Duesseldorf
Cervical Dystonia
05/24
07/24
BvsB, NCT05617118: BTA vs Baclofen for Pelvic Myofascial Pain Syndrome

Recruiting
N/A
52
RoW
Baclofen 10mg, Baclosan, Botulinum toxin type A, Botox, Xeomin, Dysport
Saint Petersburg State University, Russia, Ural State Medical University
Chronic Pain, Chronic Pelvic Pain Syndrome, Myofascial Pain Syndrome, Myofascial Trigger Point Pain, Pelvic Floor Disorders
12/23
05/24
NCT06386848: Strategy to Adapt Botulinum Toxin Doses in Dystonia

Not yet recruiting
N/A
100
NA
Botulinum toxin, onabotulinumtoxinA, abobotulinumtoxinA, incobotulinumtoxinA
Central Hospital, Nancy, France
Dystonia
05/24
06/24
NCT06485440: The Effects of Preoperative Botulinum Toxin A Injection on Respiratory System Function

Completed
N/A
30
Europe
Dysport 300 UNT Injection, BTA Injections
Swissmed Hospital
Botulinum Toxins, Type A, Hernia
01/25
03/25
CLIN-52120-456, NCT05224349: Effectiveness and Safety of SMART [Spastic Muscle Palpation by Anatomic Landscape for BoNT-A (Botulinumtoxin-A) Injection to Reduce Muscle Tone] BoNT-A Therapy With Dysport® in Patients With Post-stroke Chronic Upper Limb Spasticity (ULS) in Real-life Setting.

Active, not recruiting
N/A
121
Europe
Ipsen
Post-Stroke Chronic Upper Limb Spasticity
04/25
08/25
NCT05403710: Botulinum Toxin Therapy in Hidradenitis Suppurativa

Recruiting
N/A
20
US
Botulinum toxin, Botox
University of Massachusetts, Worcester, Hidradenitis Suppurativa Foundation, National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Hidradenitis Suppurativa, Hyperhidrosis
04/28
04/28
ROM-ICTUS, NCT05151874: Valuation of the Evolution of Passive Mobility in the Spastic Upper Limb After Injection of Abobotulinumtoxin(Dysport®)

Not yet recruiting
N/A
12
Europe
Abobotulinum toxin A, toxin infiltration
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
Spasticity, Muscle, Stroke Sequelae, Movement Disorders
12/22
12/22
Botox (onabotulinumtoxin A) / GSK, AbbVie, Healis Therap
ACTRN12611001270909: BOTOX for vocal cord dysfunction in severe asthma

Not yet recruiting
4
46
 
Prof Philip Bardin
Severe asthma, Vocal cord Dysfunction
 
 
ACTRN12605000515695: Open label longitudinal study of Botox and chronic pelvic pain 03/102

Active, not recruiting
4
58
 
Allergan Pty Ltd, Allergan Pty Ltd
Chronic pelvic pain
 
 
ACTRN12622001433796: Arthroscopic Stiff Elbow release and Botox

Recruiting
4
20
 
John Trantalis, Orthocentre
Elbow Contracture
 
 
2005-004685-17: A prospective placebo controlled study of botulilium toxin (BOTOX) on gait disorder induced by spastic equinovarus foot.

Ongoing
4
12
Europe
BOTOX, Powder and solvent for solution for injection, BOTOX
CUB - Hôpital Erasme
Spastic equinus foot is a common dynamic deformity in patients with cerebral palsy. This dynamic deformity, mainly caused by spasticity of the soleus, gastrocnemius and tibialis posterior muscles, may lead to gait impairment.
 
 
2009-015620-29: The efficacy of the Botulinum toxin-A on the manual abilities in children with congenital spastic hemiplegia. Interest of the measure of the bimanual task performance.

Ongoing
4
30
Europe
BOTOX, 9060X, Injection*, BOTOX
The main objective of this study is to investigate the effect of Botulinum toxin A to improve the Upper Limb dysfunction in Hemiplegic Cerebral Palsy Children and in particular, its impact on Upper limb activity performance and how this might be translate in bimanual activities.
 
 
2010-018345-64: Evaluation of the efficacy of Xeomin in the treatment of cervical dystonia (CD) and blepharospasmus (BS) in patients who did not respond to treatment with Botox.

Ongoing
4
30
Europe
Powder for solution for injection, XEOMIN, BOTOX
POLICLINICO UNIVERSITARIO AGOSTINO GEMELLI
cervical dystonia, blepharospasmus (BS)
 
 
2012-002211-25: Prevention of bladder dysfunction in acute spinal cord injury with Onabotulinumtoxin A

Ongoing
4
20
Europe
Botox, Powder for concentrate for solution for injection/infusion, Botox
Oslo University Hospital, Dept of Urology, Oslo University Hospital
Bladder dysfunction after acute spinal cord injury, Bladder dysfunction after acute spinal cord injury, Diseases [C] - Nervous System Diseases [C10]
 
 
2012-005068-82: An alternative approach for treatment of infantile esotropia with botulinum toxin A.

Ongoing
4
40
Europe
Botox, RVG 32957, Powder for solution for injection, Botox
The Rotterdam Eye Hospital, Stichting Wetenschappelijk Onderzoek Oogziekenhuis – Prof. Dr. Flieringa (SWOO)
infantile esotropia, infantile esotropia, Diseases [C] - Nervous System Diseases [C10]
 
 
2004-004589-33: Tratamiento del dolor cervical crónico secundario a síndrome del latigazo cervical con toxina botulínica tipo A: estudio piloto. Estudio de fase IV, randomizado, a doble ciego y controlado con placebo.

Ongoing
4
36
Europe
BOTOX, 8881727,
Rehabilitation Department. Hospital mútua de Terrassa
LATIGAZO CERVICAL
 
 
2005-001378-29: A double blinded randomised controlled trial of injection of botulinum toxin versus normal saline into the puborectalis muscle in patients with pelvic floor dyssynergia.

Ongoing
4
20
Europe
Botox, Botox, Botox
Bradford Teaching Hospitals NHS Foundation Trust
Obstructed defeacation
 
 
2006-000129-76: Botulinum toxin-A in Sensory Urgency

Ongoing
4
64
Europe
Botulinum Toxin A, BOTOX, BOTOX
Guy\'s & St Thomas\' NHS Foundation Trust
Sensory Urinary Urgency. This is a condition where patients have urinary urgency (sudden desire to urinate which cannot be deferred) /- urge incontinence (urine leakage) and usually is accompanied by frequency (frequent passage of urine; usually > 8/day); and nocturia (passing urine at night ie getting up from sleep). No abnormal bladder muscle overactivity, however, is present.
 
 
2007-004650-93: The effect of Botulinum toxin A injections for overactive bladder on detrusor contractility

Ongoing
4
10
Europe
botulinum toxin A, BOTOX ®, BOTOX ®
University Medical Center Groningen
Neurogenic or idiopathic overactive bladder, not adequately responding to anticholinergic therapy
 
 
2006-000833-36: The Action of Botox® on Urgency – A precise evaluation of its impact on urodynamic parameters during bladder filling in patients with non-neurogenic Overactive Bladder (OAB).

Ongoing
4
14
Europe
BOTOX, BOTOX
Sheffield Teaching Hospitals NHS Foundation Trust
Non-neurogenic Overactive Bladder (OAB)
 
 
2007-003017-14: A comparison of the effect of Atropine and Botulinum-toxin in patients with severe drooling

Ongoing
4
40
Europe
Botox, Atropin Chauvin, M03AX01, S01FA01, Botox, Atropin Chauvin, Botox, Atropin Chauvin
Käkkliniken, Universitetssjukhuset i Linköping
Patients with ALS, Parkinson´s disease, brain-damage cerebral paralysis or other neurological conditions often have an impaired swallowing, resulting in drooling. This adds a social handicap and often also causes facial dermatitis, especially around the mouth.
 
 
2007-003138-41: Ensayo clínico para evaluar la seguridad de la toxina botulínica inyectada en esfínter uretral externo vía transperineal (esfinterotomía química) en la retención urinaria crónica secundaria a una lesión medular.

Ongoing
4
20
Europe
Botox, Botox
Hospital Universitario Vall d’Hebron. Barcelona. Spain
Tratamiento de la retención urinaria secundara a lesión medular.
 
 
2004-002981-39: Randomised trial of detrusor botulinum toxin injection (BOTOX®) compared to placebo in women with idiopathic detrusor overactivity

Ongoing
4
240
Europe
BOTOX®, N/A, BOTOX, BOTOX
University Hospitals of Leicester NHS Trust
Detrusor overactivity which is a disease of bladder function where unprovoked contractions of the detrusor muscle are generated during the storage phase of micturition. Symptoms include frequency, urgency, urge incontinence, nocturia. The first line treatment for this condition is with oral anticholinergic medication, which in many patients is ineffective.
 
 
2008-004584-19: Skolioser hos cerebral parese patienter behandlet med Botulinum toxin AInjektioner.

Ongoing
4
33
Europe
botox, botox, botox
University hospital of Hvidovre
Scoliosis in patients with cerebral palsy
 
 
2009-009868-31: Quality of life, gross motor function, and actual everyday physical activity level in children with spastic Cerebral Palsy: (cost)effectiveness of combined treatment with multilevel botulinum-toxin injections and intensive functional physiotherapy.

Ongoing
4
60
Europe
Botox, NDC 0023-1145-01, Botox, Botox
ZonMW
Spastic Cerebral Palsy, GMFCS levels I-III
 
 
2009-017308-10`ACTRN12621000314820: ”Lasten idiopaattisen varvaskävelyn botuliinihoito – satunnaistettu kontrolloitu arvioijasokkoutettu tutkimus”

Ongoing
4
30
Europe
Botox, Botox
Heli Sätilä, Army School of Health
Peripheral intravenous catheter failure, Shock, haemorrhage
 
 
2015-001680-40: Bladder instillation of Botox with iontophoresis for overactive bladder - a pilot study

Ongoing
4
15
Europe
Botox, Powder for injection, Botox
Vestfold Hospital, Vestfold Hospital, South-Eastern Norway Regional Health Authority
Overactive bladder, Overactive bladder means a sudden, strong urge to void, often associated with incontinence of urine, Analytical, Diagnostic and Therapeutic Techniques and Equipment [E] - Therapeutic techniques [E02]
 
 
2018-001912-31: Treatment of headache attributed to temporomandibular disorder with a flat plane occlusal splint and injections of botulinum toxin Zdravljenje glavobola v zvezi s temporomandibularno motnjo z Michigansko okluzijsko opornico in injekcijami botulinum toksina

Not yet recruiting
4
120
Europe
Botox, Powder for suspension for injection, XEOMIN 100 units powder for solution for injection
UNIVERSITY MEDICAL CENTRE LJUBLJANA, UNIVERSITY MEDICAL CENTRE LJUBLJANA
Headache attributed to temporomandibular disorder Glavobol v zvezi s temporomandibularno motnjo, Headache caused by a disorder involving structures in the temporomandibular region. Glavobol, ki ga povzroča motnja, ki vključuje strukture v temporomandibularni regiji., Diseases [C] - Musculoskeletal Diseases [C05]
 
 
2019-004488-33: Botox injektion in the hip joint for pain relief and diagnosis of pain lokalisation. To seeifthe pain comes from the hipjoint or from the surrounding structures and tissue.

Not yet recruiting
4
10
Europe
Botox, Natriumklorid Fresenius Kabi 9mg/ml, Xylokain 10 mg/ml, Concentrate and solvent for solution for injection, Solution for infusion, Solution for injection, Botox, Natriumklorid Frenius Kabi 9mg/ml, Xylocain
Niels Bang, Silkeborg Regionshospital
Patients with hip pain 6 month after operation with periacetabular osteotomi for dysplastic hip., Patients with hip pain 6 month after operation for dysplastic hip., Diseases [C] - Musculoskeletal Diseases [C05]
 
 
NCT04240535: Evaluation of the Safety and Efficacy of OnabotulinumtoxinA to the Depressor Anguli Oris

Not yet recruiting
4
20
US
OnabotulinumtoxinA 50 UNT [Botox Cosmetic], Botox Cosmetic
Amir Moradi MD, MBA, Allergan
Aging
05/20
07/20
NCT04305743: Post-procedural Pain Associated With 5 Versus 20 Intravesical Injections of Onabotulinumtoxin A

Recruiting
4
60
US
OnabotulinumtoxinA 100 UNT, BOTOX
University of South Florida, Medstar Health Research Institute
Urinary Bladder, Overactive, Incontinence, Urge, Incontinence, Urinary, Urinary Urge Incontinence, Urinary Frequency More Than Once at Night, Nocturia
01/21
06/21
NCT05840445: Efficacy of Prabotulinum and Onabotulinum Toxin-A for Facial Wrinkles

Completed
4
26
RoW
Onabotulinum toxin A, Botox, Prabotulinumtoxin A, Nabota
Instituto de Oftalmología Fundación Conde de Valenciana
Face, Skin Fold, Rejuvenation
01/21
01/21
2020-005547-23: Comparison of injection with botulinum toxine or placebo (sterile saline) in the biceps muscle for cramping pain after biceps tenotomy

Not yet recruiting
4
20
Europe
Botulinum toxin type A, Solution for injection/infusion, Botox
AZ Delta vzw, Orthopedie Roeselare
Popeye sign or cramping pain after shoulder artroscopy with biceps tenotomy, Cramping pain after biceps tenotomy, Diseases [C] - Musculoskeletal Diseases [C05]
 
 
ChiCTR2100052705: Research progress of botulinum toxin in the treatment of rosacea associated erythema and flushing

Completed
4
44
 
Botox injection ;normal saline
Chengdu Second People's Hospital; Chengdu Second People's Hospital, Self funded
rosacea
 
 
2021-002819-60: Treatment of chronic anal fissure with ultrasound-guided intersphincteric infiltration of botulinum toxin A. Tratamiento de la fisura anal crónica con infiltraciones interesfinterianas ecoguiadas de toxina botulínica A

Ongoing
4
50
Europe
BOTOX
Hospital Universitario de Burgos, Hospital Universitario de Burgos
Chronic anal fissure Fisura anal crónica, Chronic anal fissure, Analytical, Diagnostic and Therapeutic Techniques and Equipment [E] - Surgical Procedures, Operative [E04]
 
 
ChiCTR2000030967: Effect of Botulinum toxin type A (BOTOX) on male pattern baldness

Recruiting
4
30
 
Botulinum toxin type A injection
Xi'an Xincheng the Doctor's Medical Aesthetic & Skin; Doctor's Medical Aesthetic & Skin, self financing
AGA
 
 
NCT04485780: Botulinum Toxin Injection in Patients Undergoing Hemorrhoidectomy-A Prospective, Randomized Study

Recruiting
4
60
RoW
botulinum toxin type A, Botox
Tri-Service General Hospital
The Influence of Timing of Botulinum Toxin Injection on Postoperative Pain Control
12/21
12/21
NCT05157295: Comparing Number of Injection Sites of In-office Intravesical Onabotulinumtoxin A Treatments for Overactive Bladder: A Randomized Controlled Trial

Not yet recruiting
4
100
NA
OnabotulinumtoxinA
Augusta University
Overactive Bladder Syndrome, Overactive Bladder
09/22
09/22
NCT05057117: Longevity of Microwave Thermolysis and Botulinum Toxin A for Treatment of Axillary Hyperhidrosis

Completed
4
30
Europe
Microwave thermolysis, miraDry, Botulinum toxin A, Botox
Merete Haedersdal
Hyperhidrosis Primary Focal Axilla
10/22
04/23
NCT06331533: Intradermal BoNT-A Treatment in Erythematotelangiectatic Rosacea

Completed
4
30
RoW
Botulinum toxin A, Botox, Placebo, %0.9 Sodium chloride
Istanbul Training and Research Hospital
Erythematotelangiectatic Rosacea
05/23
06/23
NCT04124939: Is 10 Injections of Bladder Botox Less Painful Than 20 Injections?

Completed
4
41
US
OnabotulinumtoxinA 100 Units, BOTOX
Wake Forest University Health Sciences
Overactive Bladder
11/22
02/23
2022-002192-11: Selän alueen poikkeava aktiivisuus servikaalisessa dystoniassa Selän alueen poikkeava aktiivisuus servikaalisessa dystoniassa

Not yet recruiting
4
200
Europe
Botuliinitoksiini, Concentrate and solvent for solution for injection, Botox /Xeomin
Pirkanmaan sairaanhoitopiiri, Pirkanmaan sairaanhoitopiiri
Servikaalinen dystonia, jossa poikkeavaa lihasaktiivisuutta esiintyy kaulan alueen lihaksissa aiheuttaen tyypillisiä virheasentoja kuten pään kiertymistä, kallistumista ja vapinaa. Servikaalista dystoniaa hoidetaan ensisijaisesti paikallisesti botuliinitoksiinipistoksilla, jossa poikkeavaa lihasaktiivisuutta pyritään vähentämään lamaamalla kohdelihasten toimintaa. Servikaalinen dystonia, jossa poikkeavaa lihasaktiivisuutta esiintyy kaulan alueen lihaksissa aiheuttaen tyypillisiä virheasentoja kuten pään kiertymistä, kallistumista ja vapinaa. Servikaalista dystoniaa hoidetaan ensisijaisesti paikallisesti botuliinitoksiinipistoksilla, jossa poikkeavaa lihasaktiivisuutta pyritään vähentämään lamaamalla kohdelihasten toimintaa., Servikaalinen dystonia, jossa poikkeavaa lihasaktiivisuutta esiintyy kaulan alueen lihaksissa aiheuttaen tyypillisiä virheasentoja kuten pään kiertymistä, kallistumista ja vapinaa Servikaalinen dystonia, jossa poikkeavaa lihasaktiivisuutta esiintyy kaulan alueen lihaksissa aiheuttaen tyypillisiä virheasentoja kuten pään kiertymistä, kallistumista ja vapinaa, Diseases [C] - Nervous System Diseases [C10]
 
 
SEPTOX, NCT04819360: Botulinum Toxin a Vs Anticholinergic Treatment of Neurogenic Overactive Bladder in Patients with Multiple Sclerosis

Terminated
4
1
Europe
VESIcare 10Mg Tablet, Vesicare, Botox 100 UNT Injection, Botox
Brigitte Schürch, Centre Hospitalier Universitaire Vaudois
Urinary Bladder, Neurogenic, Multiple Sclerosis
03/22
04/24
STAR, NCT05277337 / 2021-004748-62: Study Comparing Treatment With Alluzience vs Reconstituted Toxin

Completed
4
150
Europe
Alluzience, powder BoNT-A (BOTOX/Vistabel)
Galderma R&D
Glabellar Frown Lines
10/22
10/22
SBD-BOT-OAB, NCT06796855: Comparing Treatments for Refractory Overactive Bladder: Bladder Denervation Vs Botulinum Toxin Injections

Completed
4
60
RoW
Selective Bladder Denervation via Radiofrequency Ablation, Intravesical Onabotulinum Toxin A Injection
Bagcilar Training and Research Hospital
Overactive Bladder Syndrome, Refractory Overactive Bladder
02/24
02/24
EVEC, NCT05284019: Real World Effectiveness of Eptinezumab in Participants With Migraine

Terminated
4
32
US
Eptinezumab, Vyepti, Erenumab, Aimovig®, Onabotulinumtoxin-A, Fremanezumab, Ajovy®, Galcanezumab, Emgality®
H. Lundbeck A/S
Migraine
02/23
04/23
2021-000877-10: Comparison of microwaves thermolysis and botulinum toxin A for treatment of increased sweat from armpits Sammenligning af mikrobølge-termolyse og botulinum toxin A til behandling af øget armhulesved

Not yet recruiting
4
30
Europe
Powder for solution for injection, BOTOX
Bispebjerg Hospital, Department of Dermatology, MiraDry, Sientra
Axillary hyperhidrosis, Excessive armpit sweat, Diseases [C] - Skin and Connective Tissue Diseases [C17]
 
 
NCT04807920: BOTOX® at the Time of Prolapse Surgery for OAB

Recruiting
4
138
US
OnabotulinumtoxinA 100 UNT, Injectable saline, Placebo
Walter Reed National Military Medical Center
Urinary Bladder, Overactive, Pelvic Organ Prolapse
06/23
06/23
NCT05719285: Prophylactic Antibiotic Administration for Bladder OnabotulinumtoxinA Injection

Completed
4
100
US
Single-Dose Antibiotic, ARM 1: Single-Dose Antibiotic Prophylaxis, Multi-Dose Antibiotic, ARM 2: Multi-Dose Antibiotic Prophylaxis
The Cleveland Clinic
Overactive Bladder, Overactive Bladder Syndrome, Urge Incontinence, Urinary Incontinence, Urge
06/23
06/23
NCT04270526: Minimizing Pain During Office Intradetrussor Botox Injection

Completed
4
85
US
Bicarbonate protocol, Standard protocol
Boston Urogynecology Associates
Overactive Bladder, Overactive Detrusor, Overactive Bladder Syndrome, Overactivity; Behavior, Urge Incontinence
06/23
06/23
BIND, NCT05652036: Procedural Discomfort Related to Number of Intradetrusor Botox Injections

Completed
4
108
US
Intradetrusor Botox Injections
The Methodist Hospital Research Institute
Overactive Bladder
04/23
05/23
NCT03381261: (Botox) Mechanisms of Action in Altering the Molecular Environment in Which Pain Fibers Exist

Completed
4
37
US
Botulinum toxin type A, Botox
Massachusetts General Hospital, Beth Israel Deaconess Medical Center
Migraine
08/23
12/23
NCT06724250: Biofeedback Therapy Versus Botox Injection in Treatment of Dyssynergic Defecation.

Completed
4
78
RoW
Biofeedback therapy, Botulinum Toxin A (Botox )
Mansoura University
Obstructed Defaecation Syndrome
08/24
09/24
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Dysport (abobotulinumtoxinA) / Ipsen
2004-005194-27: Anti-inflammatory and/or antinociceptive effects of botulinum toxin A in an experimental inflammatory human skin pain model: a randomised, double blinded, placebo controlled study

Ongoing
4
6
Europe
Dysport, 11101-0309-6, Solution for injection
Department of Neurology, Medical University of Vienna
not applicableIn this trial a potential antinociceptive potency af the IMP (Dysport) will be testet i9n a human inflammatory pain model. The present study will only include heathy volunteers.
 
 
2005-004011-30: A prospective open study evaluating the use of botulinum toxin in patients with overactive bladder as an alternative to other conservative treatments.

Ongoing
4
100
Europe
Dysport, botulinum toxin, Dysport, Dysport
Gwent Healthcare NHS Trust
Overactive bladder syndrome is characterized by a combination of urinary frequency, urgency and urge incontinence.
 
 
2008-005819-18: A comparison of Dysport (100 U/ml) and Botox (100 U/ml) using dose conversion factor 3:1 and 1.7:1 in the treatment of cervical dystonia.

Ongoing
4
75
Europe
Botox, Dysport, Botox, Dysport, Botox, Dysport
Department of Neuroscience, Uppsala University
Cervical dystonia, not multifocal or generalised dystonia.
 
 
2009-012073-34: Botulinum toxin for treating calf muscle spasticity in Hereditary Spastic Paraparesis (HSP): functional effects on dynamic balance and gait

Ongoing
4
20
Europe
Dysport, Dysport, Dysport
Radboud University Nijmegen Medical Centre
Subjects with hereditary spastic paraparesis (HSP)
 
 
2009-013684-19: Studie av botulinumtoxiners anhidrotiska (svettreducerande) effekt beroende på använd koncentration.

Ongoing
4
20
Europe
Botox, Dysport, Xeomin, Neurobloc, Botox, Dysport, Xeomin, Neurobloc, Botox, Dysport, Xeomin, Neurobloc
Uppsala läns landsting
Studien kommer att utföras på friska försökspersoner. Anhidrotisk (svettreducerande) effekt samt durationen av denna kommer att undersökas efter injektioner med botulinumtoxin.Resultaten från studien kommer senare att appliceras vid behandling av patienter med sjukdomen hyperhidros.
 
 
2010-021265-80: Injections intradétrusoriennes de toxine botulique A chez l\'enfant présentant un syndrome d\'hyperactivité vésicale neurogène : essai thérapeutique contrôlé multicentrique de non infériorité entre deux doses rapportées au poids.

Ongoing
4
250
Europe
DYSPORT 500 UNITES SPEYWOOD, DYSPORT 500 UNITES SPEYWOOD
Centre Hospitalier Universitaire de Reims
Syndrome d\'hyperactivité vésicale neurogène chez l\'enfant
 
 
2012-002938-37: NA Comprobación del efecto clínico de tres toxinas botulínicas tipo A, sobre líneas verticales del entrecejo (líneas glabelares).

Ongoing
4
60
Europe
Vistabel, Bocouture, Azzalure, Vistabel, Bocouture, Azzalure, Vistabel®, Bocouture®, Azzalure®, Vistabel®, Bocouture®, Azzalure®
DR. JAVIER ANIDO RUBIO, Merz Pharma S.A
NA Se trata de sujetos que requieren tratamiento con toxina botulínica para las arrugas del entrecejo (líneas glabelares) de moderadas a profundas.
 
 
2016-001378-13: A randomized, sham-controlled trial which compare the deep brain stimulation of a specific brain region against a conventional botulinum toxine treatment for cervical dystonia. Eine randomisierte, scheinkontrollierte Studie, die die tiefe Hirnstimulation eine speziellen Hirnregion mit einer herkömmlichen Botulinumtoxintherapie bei zervikaler Dystonie vergleicht.

Not yet recruiting
4
66
Europe
Botulinumtoxin Type A, Powder for solution for injection, Botox(R) 50, Botox(R) 100, Botox(R) 200, Dysport(R) 300, Dysport(R) 500, XEOMIN(R) 50, XEOMIN(R) 100
University Hospital Wuerzburg, Federal Ministry of Education and Research (BMBF), Medtronic GmbH
cervical dystonia zervikale Dystonie, Torticollis spasmodicus Schief- bzw. Fehlhaltung des Halses, Diseases [C] - Nervous System Diseases [C10]
 
 
2017-004497-33: Measuring effects on pain and quality of life after botulinium injections (DYSPORT® ) in children with cerebral palsy Effekten af Botulinum toxin A injektioner (DYSPORT®) på muskelsmerter og livskvalitet hos børn med cerebral parese

Ongoing
4
36
Europe
DYSPORT® (abotulinumtoxinA), Injection, DYSPORT® (abotulinumtoxinA)
Copenhagen University Hospital at Hvidovre, Ipsen
Muscle pain in the lower extremities due to spasticity in children with cerebral palsy, Muscle pain in the legs due to spasticity in children with cerebral palsy, Diseases [C] - Nervous System Diseases [C10]
 
 
NCT06250543: Evaluation of Intradetrusor AbobotulinumtoxinA and IncobotulinumtoxinA in Women With Overactive Bladder

Completed
4
64
Europe
AbobotulinumtoxinA 300 UNT, IncobotulinumtoxinA 100 UNT, Lidocain, placebo
Niko Kavcic
Overactive Bladder
11/22
11/22
NCT02840838: Botulinum Toxin for Post Abdominoplasty Pain Control

Not yet recruiting
4
50
NA
Dysport, Placebo
Virginia Commonwealth University
Pain, Activity
12/19
12/19
NCT03136341: A Cross Over Pilot Study of Abobotulinum Toxin A (Dysport) as a Treatment for Task-dependent Upper Limb Tremor

Recruiting
4
25
US
Abobotulinum toxin A, Placebo
David M. Simpson, Ipsen
Tremor, Limb
12/22
12/22
NCT06336785: Kiss and Smile HIT (Holistic Individualized Treatment)

Completed
4
24
Canada
Restylane line of soft tissue fillers and Dysport neuromodulator
Erevna Innovations Inc.
Aesthetic
11/24
12/24
NCT03935295: Dysport ® as an Adjunctive Treatment to Bracing in the Management of Adolescent Idiopathic Scoliosis

Recruiting
4
90
US
AbobotulinumtoxinA, Dysport, Ipsen, Placebos, Custom Thoracolumbosacral Orthosis
Johns Hopkins University
Adolescent Idiopathic Scoliosis
12/25
03/26
DIRECTION, NCT04936542 / 2021-000161-32: A Study to Compare the Safety and Efficacy of Dysport® and Botox® in Adults With Upper Limb Spasticity.

Active, not recruiting
4
464
Europe, Canada, US
AboBoNT-A, Dysport®, OnaBoNT-A, Botox®
Ipsen, Ipsen Pharma
Upper Limb Spasticity
10/25
10/25
CECS, NCT05466539: Chronic Exertional Compartment Syndrome () Treated With Abobotulinumtoxin A

Recruiting
4
42
US
AbobotulinumtoxinA, Intervention Group, Placebo, Control Group
Emory University, Ipsen
Compartment Syndrome of Leg
07/25
07/25
2018-003231-30: EFFECTIVENESS OF REPEATED INJECTIONS OF BOTULINUM TOXIN IN THE GAIT AND QUALITY OF LIFE OF ADULT PATIENTS WITH WEAKNESS AND MUSCLE RIGIDITY DUE TO MULTIPLE ESCLEROSIS EFICACIA DE INYECCIONES REPETIDAS DE TOXINA BOTULÍNICA EN LA MARCHA Y CALIDAD DE VIDA DE PACIENTES ADULTOS CON DEBILIDAD Y RIGIDEZ MUSCULAR DEBIDA A ESCLÉROSIS MÚLTIPLE

Ongoing
3
84
Europe
Powder for solution for injection, Dysport
Aránzazu Vázquez Doce, IPSEN
Multiple sclerosis Esclérosis múltiple, Multiple sclerosis Esclérosis múltiple, Diseases [C] - Nervous System Diseases [C10]
 
 
2021-000161-32: A Study to Compare the Safety and Efficacy of Dysport® and Botox® in Adults with Upper Limb Spasticity Étude visant à comparer l’innocuité et l’efficacité du Dysport® par rapport au Botox® dans le traitement de patients adultes atteints de spasticité du membre supérieur

Not yet recruiting
3
564
Europe
Powder for solution for injection, Dysport® 500 U powder for solution for injection, Botox® 200 U powder for solution for injection
Ipsen Pharma, Ipsen Pharma
upper limb spasticity (ULS) of any aetiology (in US and France) or post-stroke ULS (in Canada) spasticité du membre supérieur (SMS) de toute étiologie (aux USA et en France) ou SMS postérieure à un accident vasculaire cérébral (au Canada), Upper limb spasticity is a medical condition when upper limb muscles are tight or in spasm and need to be relaxed. La spasticité du membre supérieur est une condition médicale dans laquelle les muscles dans membres supérieurs sont tendus ou contractés et ont besoin d'être relâchés, Diseases [C] - Nervous System Diseases [C10]
 
 
DNHFS, NCT04589364: Study of Abobotulinum Toxin Versus Neubotulinum Toxin Injection For Hemifacial Spasm in Thai Patients

Not yet recruiting
3
120
RoW
Injection botulinum toxin A ( Dysport 100 unit or Neuronox 33.33 unit)
Rajavithi Hospital
Hemifacial Spasm
06/26
08/26
NCT06946160: A Non-inferiority Clinical Trial to Compare Efficacy and Safety of Abobotulinumtoxin A (Espad Pharmed) Versus AbobotulinumtoxinA (Dysport®, Ipsen Co.) for Correction of Moderate to Severe Glabellar Lines

Completed
3
146
RoW
Abobotulinumtoxin A for Injection
Espad Pharmed, Center for Research and Training in Skin Diseases and Leprosy
Glabellar Lines, Glabellar Wrinkle
02/25
02/25
C-BEOND, NCT06047444: A Study to Evaluate the Effectiveness and Safety of Dysport® for the Prevention of Chronic Migraine in Adults

Recruiting
3
720
Europe, Canada, US, RoW
Botulinum toxin type A, Dysport®, Placebo
Ipsen
Chronic Migraine
06/26
12/26
E-BEOND, NCT06047457: A Study to Evaluate the Effectiveness and Safety of Dysport® for the Prevention of Episodic Migraine in Adults

Recruiting
3
714
Europe, Canada, US, RoW
Botulinum toxin type A, Dysport®, Placebo
Ipsen
Episodic Migraine
06/26
12/26
NCT04756882: Clinical Evaluation of the Efficacy OF Botulinum Toxin A for Improving Facial Scars

Active, not recruiting
2/3
12
RoW
AbobotulinumtoxinA 500 UNT, Dysport
Alexandria University
Hypertrophic Scarring
05/21
09/21
EBTox, NCT03453632: Injections of Botulinic Toxin in Plantar Lesions of Localized Epidermolysis Bullosa Simplex

Recruiting
2/3
25
Europe
Botulinic toxin, Dysport® (experimental drug), Placebo, physiological serum
University Hospital, Toulouse
Epidermolysis Bullosa Simplex
09/23
12/23
NCT05478551: Randomized Controlled Trial Examining the Efficacy of Botulinum Toxin in Biopsy Scar Minimization

Active, not recruiting
2/3
12
US
Botulinum Toxin, Dysport, BTXa, abobotulinumtoxinA, Normal saline, Placebo
Henry Ford Health System
Scar, Hypertrophic Scar
12/24
12/24
NCT03887377: The Efficacy and Molecular Mechanism of Botulinum Toxin in the Reduction of Breast Reduction Mammoplasty Scar Formation

Enrolling by invitation
2/3
22
US
Botulinum Toxins, Dysport, BTXa, abobotulinumtoxinA, Normal saline, Placebo
Henry Ford Health System, Galderma R&D
Scar, Hypertrophic Scar, Mammary Disorder
12/24
12/24
2012-003479-20: Study of treatment of tennis elbow with Botox. Undersökning av behandling av tennisarmbåge med Botox

Ongoing
2
50
Europe
botulinum toxin, Powder for solution for injection, Dysport
Handkirurgiska kliniken, Universitetssjukhuset Örebro, Handkirurgiska kliniken, Universitetssjukhuset Örebro
Chronic lateral humerus epiconcylitis Kronisk lateral humerusepikondylit., Tennis elbow Tennisarmbåge., Diseases [C] - Musculoskeletal Diseases [C05]
 
 
2005-005235-96: A Double-Blind Comparison of the Safety and Efficacy of Dysport® and BOTOX® (Botulinum Toxin Type A) in the Treatment of Female Subjects with Severe Glabellar Rhytids

Ongoing
2
60
Europe
BOTOX®, Dysport®, N/A, BOTOX®, Dysport®, BOTOX®, Dysport®
Cranley Clinic
Severe glabellar rhytids
 
 
2005-004996-40: A Prospective, Single-Arm, Open-label Study to Investigate the Efficacy and Safety of Intravesical Injection of Botulinum Toxin Type-A (750 Units Dysport®) for the Management of Neurogenic Detrusor Overactivity.

Ongoing
2
50
Europe
Dysport, N/A, Dysport, Dysport
R and D Department, Cardiff and the Vale NHS Trust
Neurogenic detrusor overactivity
 
 
2005-004995-20: A Prospective, Single-Arm, Open-label Study to Investigate the Efficacy and Safety of Intravesical Injection of Botulinum Toxin Type-A (500 Units Dysport®) for the Management of Idiopathic Overactive Bladder Syndrome.

Ongoing
2
50
Europe
Dysport, N/A, Dysport, Dysport
R and D Department, Cardiff and the Vale NHS Trust
Idiopathic Overactive bladder syndrome
 
 
2010-022165-10: Klinische Studie zur Induktion einer Apoptose von Prostatazellen durch die Injektion von Botulinumtoxin A bei Patienten mit benigner Prostatahyperplasie

Ongoing
2
35
Europe
Dysport® 500 Einheiten, Pulver zur Herstellung einer Injektionslösung, Dysport® 500 Einheiten, Pulver zur Herstellung einer Injektionslösung
Prim. Univ.-Prof. Dr. Günter Janetschek c/o Universitätsklinik für Urologie und Andrologie
Benigne Prostatahyperplasie mit Inoperabilität und transurethralem Dauerkatheter
 
 
2018-001703-37: Dysport in Post-Surgical Neuralgia (RESPITE)

Not yet recruiting
2
60
Europe
Dysport, Solution for infusion, Dysport
Ipsen Innovation SAS, Ipsen Innovation SAS
Post-Surgical neuralgia, Chronic scar-related pain after surgery, Diseases [C] - Nervous System Diseases [C10]
 
 
2019-003503-35: Studies of the treatment effect of botulinum toxin A on patients with neurogenic pain in the mouth

Not yet recruiting
2
37
Europe
Powder for solution for injection, Dysport
Region Östergötland, Folktandvården, Region Östergötland
Atypical Odontalgia/Persistent Dentoalveolar Pain, Neurogenic pain in the mouth, Analytical, Diagnostic and Therapeutic Techniques and Equipment [E] - Dentistry [E06]
 
 
2021-006048-29: BotulInum toxin type A for peripheral Neuropathic pain in subjEcts with Carpal Tunnel syndrome: a multicenter, randomized, double-blind, placebo-controlled study Studio multicentrico, randomizzato, in doppio cieco, controllato con placebo per valutare l’efficacia e la sicurezza della tossina botulinica di tipo A per il dolore neuropatico periferico in soggetti con sindrome del tunnel carpale.

Not yet recruiting
2
164
Europe
Tossina botulinica tipo A da C. botulinum complesso - emoagglutinina, [Dysport 500 unità], Powder and solvent for solution for injection/infusion, Dysport
AOU MATERDOMINI, Ipsen
Peripheral neuropathic pain in subjects with carpal tunnel syndrome Dolore neuropatico periferico in soggetti con sindrome del tunnel carpale, Peripheral neuropathic pain in subjects with carpal tunnel syndrome Dolore neuropatico periferico in soggetti con sindrome del tunnel carpale, Body processes [G] - Bones and nerves physological processes [G11]
 
 
NCT04965311: Endoscopic Botulinum Toxin Injection in the Prevention of Postoperative Pancreatic Fistula Following Distal Pancreatectomy

Recruiting
2
63
US
Botulinum Toxin Type A, AbobotulinumtoxinA, Botox, Botox Cosmetic, Botulinum A Toxin, Botulinum Neurotoxin Type A, Botulinum Toxin A, BTX-A, DaxibotulinumtoxinA, Dysport, EvabotulinumtoxinA, IncobotulinumtoxinA, OnabotulinumtoxinA, Onaclostox, Prabotulinumtoxin A, Xeomin
OHSU Knight Cancer Institute, Oregon Health and Science University
Pancreatic Carcinoma
05/25
05/25
2019-003948-71: A study investigating single injection of new botulinum toxin to determine safety and efficacy for treating spasticity in the upper limb

Ongoing
1/2
209
Europe, RoW
Dysport, IPN59011, Powder and solvent for solution for injection, Powder for solution for injection, Dysport
Ipsen Innovation, IPSEN INNOVATION, Ipsen Innovation
Upper limb spasticity after stroke or traumatic brain injury, Medical condition where Upper limb muscles are tight or in spasm after stroke or traumatic brain injury and needs to be relaxed., Diseases [C] - Nervous System Diseases [C10]
 
 
2020-003746-36: A study to assess the safety and efficacy of IPN10200 in adult participants with moderate to severe upper facial lines

Not yet recruiting
1/2
547
Europe
Dysport, IPN10200, Powder for solution for injection, Dysport
Ipsen Innovation, Ipsen Innovation
Treatment of Moderate to Severe Upper Facial Lines, Treatment of Moderate to Severe Upper Facial Lines, Body processes [G] - Physical Phenomena [G01]
 
 
NCT04886167: Dysport Dose-Ranging Treatment of Platysmal Bands

Active, not recruiting
1/2
30
US
AbobotulinumtoxinA, Dysport
Clinical Testing of Beverly Hills, Galderma R&D
Platysma Bands
11/22
11/22
LANTIC, NCT04821089 / 2020-003746-36: A Study to Assess the Safety and Efficacy of IPN10200 in Adult Participants With Moderate to Severe Upper Facial Lines

Recruiting
1/2
727
Europe
IPN10200, IPN10200 Placebo, Dysport
Ipsen, Ipsen Innovation
Moderate to Severe Upper Facial Lines
03/26
03/27
LANTIMA, NCT04752774 / 2020-003623-42: A Study to Assess the Safety and Efficacy of IPN10200 in Adult Participants With Upper Limb Spasticity.

Active, not recruiting
1/2
240
Europe, US, RoW
IPN10200, Placebo, Dysport
Ipsen
Spasticity
10/27
10/27
ACTRN12605000775617: Effectiveness of Botulinum toxin Type A injection (Dysport®) to restore quadriceps muscle balance and improve chronic knee pain

Active, not recruiting
1
25
 
Dr BJ Singer, School of Surgery and Pathology, The University of Western AustraliaMedical Research Foundation Building, Level 2, Rear 50 Murray Street, Perth, WA 6000, Raine Medical Research Foundation, Ipsen Pharmaceuticals
Chronic anterior knee pain?
 
 
EARLY BOT-SPAS, NCT06811142: Early Botulinum Toxin for Muscle Stiffness Reduction in First-Time Stroke Patients: Improving Recovery and Independence

Active, not recruiting
1
200
RoW
Botulinum Toxin Type A (BoNT-A), Botulinum Neurotoxin A, BoNT-A, AbobotulinumtoxinA
Instituto Mexicano del Seguro Social
Spasticity, Stroke, Neurological Rehabilitation
02/27
02/30
BTX, NCT06258070: Clinical Performance of Therapeutic Use of for Bruxism

Completed
N/A
67
RoW
Abobotulinumtoxin A injection for bruxism, Botulinum toxin injection for bruxism
Mohamed Tahar Maamouri University Hospital
Myofascial Pain Syndrome, Myofascial Trigger Point Pain, Bruxism, Pain
12/15
12/17
NCT04270214: Conversion to Dysport in CD

Active, not recruiting
N/A
33
Canada
Dysport Injectable Product, abobotulinumtoxinA
Western University, Canada
Cervical Dystonia
10/22
10/22
JBDX, NCT05167864: Evaluation of Four Injectable Neuromodulators in the Glabella Area Glabella Area

Completed
N/A
143
US
Onabotulinumtoxina for Injection, Botox, Abobotulinumtoxina for Injection, Dysport, IncobotulinumtoxinA for Injection, Xeomin, PrabotulinumtoxinA for Injection, Jeuveau
University of Pennsylvania
Cosmetic Techniques
06/23
06/23
NCT05089357: Non-interventional Study, Long Term Treatment on Glabellar Lines With Dysport® in Subjects of Chinese Origin

Completed
N/A
250
RoW
AbobotulinumtoxinA
Galderma R&D
Glabellar Lines
09/23
12/23
CARBUR, NCT06245772: CARegiver BURden, Effectiveness and Other Health Care Measures on Functional Disability, in Patients Treated With Abobotulinumtoxin A for Upper Limb Spasticity

Recruiting
N/A
133
Europe
Ipsen
Upper Limb Injury
07/25
09/26
RELY-CD, NCT05884528: Assessment of Long-term Clinical Response to BoNT in Cervical Dystonia

Completed
N/A
270
Europe
CC BoNT/A, onabotulinumtoxinA, abobotulinumtoxinA, CF BoNT/A, incobotulinumtoxinA, NT 201, Botulinum toxin type A (150 kiloDalton), free from complexing proteins, CF to CC BoNT/A, CC to CF BoNT/A
Merz Therapeutics GmbH, Heinrich-Heine University, Duesseldorf
Cervical Dystonia
05/24
07/24
BvsB, NCT05617118: BTA vs Baclofen for Pelvic Myofascial Pain Syndrome

Recruiting
N/A
52
RoW
Baclofen 10mg, Baclosan, Botulinum toxin type A, Botox, Xeomin, Dysport
Saint Petersburg State University, Russia, Ural State Medical University
Chronic Pain, Chronic Pelvic Pain Syndrome, Myofascial Pain Syndrome, Myofascial Trigger Point Pain, Pelvic Floor Disorders
12/23
05/24
NCT06386848: Strategy to Adapt Botulinum Toxin Doses in Dystonia

Not yet recruiting
N/A
100
NA
Botulinum toxin, onabotulinumtoxinA, abobotulinumtoxinA, incobotulinumtoxinA
Central Hospital, Nancy, France
Dystonia
05/24
06/24
NCT06485440: The Effects of Preoperative Botulinum Toxin A Injection on Respiratory System Function

Completed
N/A
30
Europe
Dysport 300 UNT Injection, BTA Injections
Swissmed Hospital
Botulinum Toxins, Type A, Hernia
01/25
03/25
CLIN-52120-456, NCT05224349: Effectiveness and Safety of SMART [Spastic Muscle Palpation by Anatomic Landscape for BoNT-A (Botulinumtoxin-A) Injection to Reduce Muscle Tone] BoNT-A Therapy With Dysport® in Patients With Post-stroke Chronic Upper Limb Spasticity (ULS) in Real-life Setting.

Active, not recruiting
N/A
121
Europe
Ipsen
Post-Stroke Chronic Upper Limb Spasticity
04/25
08/25
NCT05403710: Botulinum Toxin Therapy in Hidradenitis Suppurativa

Recruiting
N/A
20
US
Botulinum toxin, Botox
University of Massachusetts, Worcester, Hidradenitis Suppurativa Foundation, National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Hidradenitis Suppurativa, Hyperhidrosis
04/28
04/28
ROM-ICTUS, NCT05151874: Valuation of the Evolution of Passive Mobility in the Spastic Upper Limb After Injection of Abobotulinumtoxin(Dysport®)

Not yet recruiting
N/A
12
Europe
Abobotulinum toxin A, toxin infiltration
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
Spasticity, Muscle, Stroke Sequelae, Movement Disorders
12/22
12/22
Botox (onabotulinumtoxin A) / GSK, AbbVie, Healis Therap
ACTRN12611001270909: BOTOX for vocal cord dysfunction in severe asthma

Not yet recruiting
4
46
 
Prof Philip Bardin
Severe asthma, Vocal cord Dysfunction
 
 
ACTRN12605000515695: Open label longitudinal study of Botox and chronic pelvic pain 03/102

Active, not recruiting
4
58
 
Allergan Pty Ltd, Allergan Pty Ltd
Chronic pelvic pain
 
 
ACTRN12622001433796: Arthroscopic Stiff Elbow release and Botox

Recruiting
4
20
 
John Trantalis, Orthocentre
Elbow Contracture
 
 
2005-004685-17: A prospective placebo controlled study of botulilium toxin (BOTOX) on gait disorder induced by spastic equinovarus foot.

Ongoing
4
12
Europe
BOTOX, Powder and solvent for solution for injection, BOTOX
CUB - Hôpital Erasme
Spastic equinus foot is a common dynamic deformity in patients with cerebral palsy. This dynamic deformity, mainly caused by spasticity of the soleus, gastrocnemius and tibialis posterior muscles, may lead to gait impairment.
 
 
2009-015620-29: The efficacy of the Botulinum toxin-A on the manual abilities in children with congenital spastic hemiplegia. Interest of the measure of the bimanual task performance.

Ongoing
4
30
Europe
BOTOX, 9060X, Injection*, BOTOX
The main objective of this study is to investigate the effect of Botulinum toxin A to improve the Upper Limb dysfunction in Hemiplegic Cerebral Palsy Children and in particular, its impact on Upper limb activity performance and how this might be translate in bimanual activities.
 
 
2010-018345-64: Evaluation of the efficacy of Xeomin in the treatment of cervical dystonia (CD) and blepharospasmus (BS) in patients who did not respond to treatment with Botox.

Ongoing
4
30
Europe
Powder for solution for injection, XEOMIN, BOTOX
POLICLINICO UNIVERSITARIO AGOSTINO GEMELLI
cervical dystonia, blepharospasmus (BS)
 
 
2012-002211-25: Prevention of bladder dysfunction in acute spinal cord injury with Onabotulinumtoxin A

Ongoing
4
20
Europe
Botox, Powder for concentrate for solution for injection/infusion, Botox
Oslo University Hospital, Dept of Urology, Oslo University Hospital
Bladder dysfunction after acute spinal cord injury, Bladder dysfunction after acute spinal cord injury, Diseases [C] - Nervous System Diseases [C10]
 
 
2012-005068-82: An alternative approach for treatment of infantile esotropia with botulinum toxin A.

Ongoing
4
40
Europe
Botox, RVG 32957, Powder for solution for injection, Botox
The Rotterdam Eye Hospital, Stichting Wetenschappelijk Onderzoek Oogziekenhuis – Prof. Dr. Flieringa (SWOO)
infantile esotropia, infantile esotropia, Diseases [C] - Nervous System Diseases [C10]
 
 
2004-004589-33: Tratamiento del dolor cervical crónico secundario a síndrome del latigazo cervical con toxina botulínica tipo A: estudio piloto. Estudio de fase IV, randomizado, a doble ciego y controlado con placebo.

Ongoing
4
36
Europe
BOTOX, 8881727,
Rehabilitation Department. Hospital mútua de Terrassa
LATIGAZO CERVICAL
 
 
2005-001378-29: A double blinded randomised controlled trial of injection of botulinum toxin versus normal saline into the puborectalis muscle in patients with pelvic floor dyssynergia.

Ongoing
4
20
Europe
Botox, Botox, Botox
Bradford Teaching Hospitals NHS Foundation Trust
Obstructed defeacation
 
 
2006-000129-76: Botulinum toxin-A in Sensory Urgency

Ongoing
4
64
Europe
Botulinum Toxin A, BOTOX, BOTOX
Guy\'s & St Thomas\' NHS Foundation Trust
Sensory Urinary Urgency. This is a condition where patients have urinary urgency (sudden desire to urinate which cannot be deferred) /- urge incontinence (urine leakage) and usually is accompanied by frequency (frequent passage of urine; usually > 8/day); and nocturia (passing urine at night ie getting up from sleep). No abnormal bladder muscle overactivity, however, is present.
 
 
2007-004650-93: The effect of Botulinum toxin A injections for overactive bladder on detrusor contractility

Ongoing
4
10
Europe
botulinum toxin A, BOTOX ®, BOTOX ®
University Medical Center Groningen
Neurogenic or idiopathic overactive bladder, not adequately responding to anticholinergic therapy
 
 
2006-000833-36: The Action of Botox® on Urgency – A precise evaluation of its impact on urodynamic parameters during bladder filling in patients with non-neurogenic Overactive Bladder (OAB).

Ongoing
4
14
Europe
BOTOX, BOTOX
Sheffield Teaching Hospitals NHS Foundation Trust
Non-neurogenic Overactive Bladder (OAB)
 
 
2007-003017-14: A comparison of the effect of Atropine and Botulinum-toxin in patients with severe drooling

Ongoing
4
40
Europe
Botox, Atropin Chauvin, M03AX01, S01FA01, Botox, Atropin Chauvin, Botox, Atropin Chauvin
Käkkliniken, Universitetssjukhuset i Linköping
Patients with ALS, Parkinson´s disease, brain-damage cerebral paralysis or other neurological conditions often have an impaired swallowing, resulting in drooling. This adds a social handicap and often also causes facial dermatitis, especially around the mouth.
 
 
2007-003138-41: Ensayo clínico para evaluar la seguridad de la toxina botulínica inyectada en esfínter uretral externo vía transperineal (esfinterotomía química) en la retención urinaria crónica secundaria a una lesión medular.

Ongoing
4
20
Europe
Botox, Botox
Hospital Universitario Vall d’Hebron. Barcelona. Spain
Tratamiento de la retención urinaria secundara a lesión medular.
 
 
2004-002981-39: Randomised trial of detrusor botulinum toxin injection (BOTOX®) compared to placebo in women with idiopathic detrusor overactivity

Ongoing
4
240
Europe
BOTOX®, N/A, BOTOX, BOTOX
University Hospitals of Leicester NHS Trust
Detrusor overactivity which is a disease of bladder function where unprovoked contractions of the detrusor muscle are generated during the storage phase of micturition. Symptoms include frequency, urgency, urge incontinence, nocturia. The first line treatment for this condition is with oral anticholinergic medication, which in many patients is ineffective.
 
 
2008-004584-19: Skolioser hos cerebral parese patienter behandlet med Botulinum toxin AInjektioner.

Ongoing
4
33
Europe
botox, botox, botox
University hospital of Hvidovre
Scoliosis in patients with cerebral palsy
 
 
2009-009868-31: Quality of life, gross motor function, and actual everyday physical activity level in children with spastic Cerebral Palsy: (cost)effectiveness of combined treatment with multilevel botulinum-toxin injections and intensive functional physiotherapy.

Ongoing
4
60
Europe
Botox, NDC 0023-1145-01, Botox, Botox
ZonMW
Spastic Cerebral Palsy, GMFCS levels I-III
 
 
2009-017308-10`ACTRN12621000314820: ”Lasten idiopaattisen varvaskävelyn botuliinihoito – satunnaistettu kontrolloitu arvioijasokkoutettu tutkimus”

Ongoing
4
30
Europe
Botox, Botox
Heli Sätilä, Army School of Health
Peripheral intravenous catheter failure, Shock, haemorrhage
 
 
2015-001680-40: Bladder instillation of Botox with iontophoresis for overactive bladder - a pilot study

Ongoing
4
15
Europe
Botox, Powder for injection, Botox
Vestfold Hospital, Vestfold Hospital, South-Eastern Norway Regional Health Authority
Overactive bladder, Overactive bladder means a sudden, strong urge to void, often associated with incontinence of urine, Analytical, Diagnostic and Therapeutic Techniques and Equipment [E] - Therapeutic techniques [E02]
 
 
2018-001912-31: Treatment of headache attributed to temporomandibular disorder with a flat plane occlusal splint and injections of botulinum toxin Zdravljenje glavobola v zvezi s temporomandibularno motnjo z Michigansko okluzijsko opornico in injekcijami botulinum toksina

Not yet recruiting
4
120
Europe
Botox, Powder for suspension for injection, XEOMIN 100 units powder for solution for injection
UNIVERSITY MEDICAL CENTRE LJUBLJANA, UNIVERSITY MEDICAL CENTRE LJUBLJANA
Headache attributed to temporomandibular disorder Glavobol v zvezi s temporomandibularno motnjo, Headache caused by a disorder involving structures in the temporomandibular region. Glavobol, ki ga povzroča motnja, ki vključuje strukture v temporomandibularni regiji., Diseases [C] - Musculoskeletal Diseases [C05]
 
 
2019-004488-33: Botox injektion in the hip joint for pain relief and diagnosis of pain lokalisation. To seeifthe pain comes from the hipjoint or from the surrounding structures and tissue.

Not yet recruiting
4
10
Europe
Botox, Natriumklorid Fresenius Kabi 9mg/ml, Xylokain 10 mg/ml, Concentrate and solvent for solution for injection, Solution for infusion, Solution for injection, Botox, Natriumklorid Frenius Kabi 9mg/ml, Xylocain
Niels Bang, Silkeborg Regionshospital
Patients with hip pain 6 month after operation with periacetabular osteotomi for dysplastic hip., Patients with hip pain 6 month after operation for dysplastic hip., Diseases [C] - Musculoskeletal Diseases [C05]
 
 
NCT04240535: Evaluation of the Safety and Efficacy of OnabotulinumtoxinA to the Depressor Anguli Oris

Not yet recruiting
4
20
US
OnabotulinumtoxinA 50 UNT [Botox Cosmetic], Botox Cosmetic
Amir Moradi MD, MBA, Allergan
Aging
05/20
07/20
NCT04305743: Post-procedural Pain Associated With 5 Versus 20 Intravesical Injections of Onabotulinumtoxin A

Recruiting
4
60
US
OnabotulinumtoxinA 100 UNT, BOTOX
University of South Florida, Medstar Health Research Institute
Urinary Bladder, Overactive, Incontinence, Urge, Incontinence, Urinary, Urinary Urge Incontinence, Urinary Frequency More Than Once at Night, Nocturia
01/21
06/21
NCT05840445: Efficacy of Prabotulinum and Onabotulinum Toxin-A for Facial Wrinkles

Completed
4
26
RoW
Onabotulinum toxin A, Botox, Prabotulinumtoxin A, Nabota
Instituto de Oftalmología Fundación Conde de Valenciana
Face, Skin Fold, Rejuvenation
01/21
01/21
2020-005547-23: Comparison of injection with botulinum toxine or placebo (sterile saline) in the biceps muscle for cramping pain after biceps tenotomy

Not yet recruiting
4
20
Europe
Botulinum toxin type A, Solution for injection/infusion, Botox
AZ Delta vzw, Orthopedie Roeselare
Popeye sign or cramping pain after shoulder artroscopy with biceps tenotomy, Cramping pain after biceps tenotomy, Diseases [C] - Musculoskeletal Diseases [C05]
 
 
ChiCTR2100052705: Research progress of botulinum toxin in the treatment of rosacea associated erythema and flushing

Completed
4
44
 
Botox injection ;normal saline
Chengdu Second People's Hospital; Chengdu Second People's Hospital, Self funded
rosacea
 
 
2021-002819-60: Treatment of chronic anal fissure with ultrasound-guided intersphincteric infiltration of botulinum toxin A. Tratamiento de la fisura anal crónica con infiltraciones interesfinterianas ecoguiadas de toxina botulínica A

Ongoing
4
50
Europe
BOTOX
Hospital Universitario de Burgos, Hospital Universitario de Burgos
Chronic anal fissure Fisura anal crónica, Chronic anal fissure, Analytical, Diagnostic and Therapeutic Techniques and Equipment [E] - Surgical Procedures, Operative [E04]
 
 
ChiCTR2000030967: Effect of Botulinum toxin type A (BOTOX) on male pattern baldness

Recruiting
4
30
 
Botulinum toxin type A injection
Xi'an Xincheng the Doctor's Medical Aesthetic & Skin; Doctor's Medical Aesthetic & Skin, self financing
AGA
 
 
NCT04485780: Botulinum Toxin Injection in Patients Undergoing Hemorrhoidectomy-A Prospective, Randomized Study

Recruiting
4
60
RoW
botulinum toxin type A, Botox
Tri-Service General Hospital
The Influence of Timing of Botulinum Toxin Injection on Postoperative Pain Control
12/21
12/21
NCT05157295: Comparing Number of Injection Sites of In-office Intravesical Onabotulinumtoxin A Treatments for Overactive Bladder: A Randomized Controlled Trial

Not yet recruiting
4
100
NA
OnabotulinumtoxinA
Augusta University
Overactive Bladder Syndrome, Overactive Bladder
09/22
09/22
NCT05057117: Longevity of Microwave Thermolysis and Botulinum Toxin A for Treatment of Axillary Hyperhidrosis

Completed
4
30
Europe
Microwave thermolysis, miraDry, Botulinum toxin A, Botox
Merete Haedersdal
Hyperhidrosis Primary Focal Axilla
10/22
04/23
NCT06331533: Intradermal BoNT-A Treatment in Erythematotelangiectatic Rosacea

Completed
4
30
RoW
Botulinum toxin A, Botox, Placebo, %0.9 Sodium chloride
Istanbul Training and Research Hospital
Erythematotelangiectatic Rosacea
05/23
06/23
NCT04124939: Is 10 Injections of Bladder Botox Less Painful Than 20 Injections?

Completed
4
41
US
OnabotulinumtoxinA 100 Units, BOTOX
Wake Forest University Health Sciences
Overactive Bladder
11/22
02/23
2022-002192-11: Selän alueen poikkeava aktiivisuus servikaalisessa dystoniassa Selän alueen poikkeava aktiivisuus servikaalisessa dystoniassa

Not yet recruiting
4
200
Europe
Botuliinitoksiini, Concentrate and solvent for solution for injection, Botox /Xeomin
Pirkanmaan sairaanhoitopiiri, Pirkanmaan sairaanhoitopiiri
Servikaalinen dystonia, jossa poikkeavaa lihasaktiivisuutta esiintyy kaulan alueen lihaksissa aiheuttaen tyypillisiä virheasentoja kuten pään kiertymistä, kallistumista ja vapinaa. Servikaalista dystoniaa hoidetaan ensisijaisesti paikallisesti botuliinitoksiinipistoksilla, jossa poikkeavaa lihasaktiivisuutta pyritään vähentämään lamaamalla kohdelihasten toimintaa. Servikaalinen dystonia, jossa poikkeavaa lihasaktiivisuutta esiintyy kaulan alueen lihaksissa aiheuttaen tyypillisiä virheasentoja kuten pään kiertymistä, kallistumista ja vapinaa. Servikaalista dystoniaa hoidetaan ensisijaisesti paikallisesti botuliinitoksiinipistoksilla, jossa poikkeavaa lihasaktiivisuutta pyritään vähentämään lamaamalla kohdelihasten toimintaa., Servikaalinen dystonia, jossa poikkeavaa lihasaktiivisuutta esiintyy kaulan alueen lihaksissa aiheuttaen tyypillisiä virheasentoja kuten pään kiertymistä, kallistumista ja vapinaa Servikaalinen dystonia, jossa poikkeavaa lihasaktiivisuutta esiintyy kaulan alueen lihaksissa aiheuttaen tyypillisiä virheasentoja kuten pään kiertymistä, kallistumista ja vapinaa, Diseases [C] - Nervous System Diseases [C10]
 
 
SEPTOX, NCT04819360: Botulinum Toxin a Vs Anticholinergic Treatment of Neurogenic Overactive Bladder in Patients with Multiple Sclerosis

Terminated
4
1
Europe
VESIcare 10Mg Tablet, Vesicare, Botox 100 UNT Injection, Botox
Brigitte Schürch, Centre Hospitalier Universitaire Vaudois
Urinary Bladder, Neurogenic, Multiple Sclerosis
03/22
04/24
STAR, NCT05277337 / 2021-004748-62: Study Comparing Treatment With Alluzience vs Reconstituted Toxin

Completed
4
150
Europe
Alluzience, powder BoNT-A (BOTOX/Vistabel)
Galderma R&D
Glabellar Frown Lines
10/22
10/22
SBD-BOT-OAB, NCT06796855: Comparing Treatments for Refractory Overactive Bladder: Bladder Denervation Vs Botulinum Toxin Injections

Completed
4
60
RoW
Selective Bladder Denervation via Radiofrequency Ablation, Intravesical Onabotulinum Toxin A Injection
Bagcilar Training and Research Hospital
Overactive Bladder Syndrome, Refractory Overactive Bladder
02/24
02/24
EVEC, NCT05284019: Real World Effectiveness of Eptinezumab in Participants With Migraine

Terminated
4
32
US
Eptinezumab, Vyepti, Erenumab, Aimovig®, Onabotulinumtoxin-A, Fremanezumab, Ajovy®, Galcanezumab, Emgality®
H. Lundbeck A/S
Migraine
02/23
04/23
2021-000877-10: Comparison of microwaves thermolysis and botulinum toxin A for treatment of increased sweat from armpits Sammenligning af mikrobølge-termolyse og botulinum toxin A til behandling af øget armhulesved

Not yet recruiting
4
30
Europe
Powder for solution for injection, BOTOX
Bispebjerg Hospital, Department of Dermatology, MiraDry, Sientra
Axillary hyperhidrosis, Excessive armpit sweat, Diseases [C] - Skin and Connective Tissue Diseases [C17]
 
 
NCT04807920: BOTOX® at the Time of Prolapse Surgery for OAB

Recruiting
4
138
US
OnabotulinumtoxinA 100 UNT, Injectable saline, Placebo
Walter Reed National Military Medical Center
Urinary Bladder, Overactive, Pelvic Organ Prolapse
06/23
06/23
NCT05719285: Prophylactic Antibiotic Administration for Bladder OnabotulinumtoxinA Injection

Completed
4
100
US
Single-Dose Antibiotic, ARM 1: Single-Dose Antibiotic Prophylaxis, Multi-Dose Antibiotic, ARM 2: Multi-Dose Antibiotic Prophylaxis
The Cleveland Clinic
Overactive Bladder, Overactive Bladder Syndrome, Urge Incontinence, Urinary Incontinence, Urge
06/23
06/23
NCT04270526: Minimizing Pain During Office Intradetrussor Botox Injection

Completed
4
85
US
Bicarbonate protocol, Standard protocol
Boston Urogynecology Associates
Overactive Bladder, Overactive Detrusor, Overactive Bladder Syndrome, Overactivity; Behavior, Urge Incontinence
06/23
06/23
BIND, NCT05652036: Procedural Discomfort Related to Number of Intradetrusor Botox Injections

Completed
4
108
US
Intradetrusor Botox Injections
The Methodist Hospital Research Institute
Overactive Bladder
04/23
05/23
NCT03381261: (Botox) Mechanisms of Action in Altering the Molecular Environment in Which Pain Fibers Exist

Completed
4
37
US
Botulinum toxin type A, Botox
Massachusetts General Hospital, Beth Israel Deaconess Medical Center
Migraine
08/23
12/23
NCT06724250: Biofeedback Therapy Versus Botox Injection in Treatment of Dyssynergic Defecation.

Completed
4
78
RoW
Biofeedback therapy, Botulinum Toxin A (Botox )
Mansoura University
Obstructed Defaecation Syndrome
08/24
09/24
 

Download Options